HIV molecular immunology database
Databases
Sequence DB
Resistance DB
Immunology DB
Vaccine Trials DB
HCV Databases
Search
CTL/CD8+ search
T Helper/CD4+ search
Antibody search
Search Help
Tools
All Immuno Tools
Epilign
PeptGen
Motif Scan
Sequence Locator
ELF
Hepitopes
HLA Freq Anal
Mosaic
Epicover
Posicover
Products
Epitope Maps
Epitope Tables
HLATEM
Tools & Links
Publications
Compendia
Reviews
About the Database
How to Cite this Database
Sequence Alignments
Tutorials
Search T Helper/CD4+ T-Cell Epitope Database
HIV Protein
Proteins with
defined epitope
s
Proteins with
undefined epitope
s
- ALL -
p17
p17-p24
p24
p2p7p1p6
Protease
RT
RT-Integrase
Integrase
Vif
Vpr
Tat
Rev
Vpu
gp160
Nef
- ALL -
p24
Gag
Pol
Vif
Tat
Rev
Vpu
Env
Nef
HIV-1
Epitope
Subtype
- ALL -
A
AG
B
C
CRF02_AG
D
G
M
Immunogen
- ALL -
computer prediction
HIV-1 and GBV-C co-infection
HIV-1 and HCV co-infection
HIV-1 exposed seronegative
HIV-1 infection
HIV-1 or HIV-2 infection
in vitro stimulation or selection
peptide-HLA interaction
SHIV infection
vaccine
Vaccine details
If Immunogen is Vaccine, additional search details
Vaccine type
- ALL -
adenovirus
adenovirus type 5 (Ad5)
bacteriophage coat protein
baculovirus
canarypox
canarypox prime with gp120 boost
canarypox prime with gp160 boost
canarypox prime with recombinant protein boost
coxsackievirus
dihydrolipoyl acetyltransferase E2 protein, of Bacillus stearothermophilus
DNA
DNA prime with gp160 boost
DNA prime with modified vaccinia Ankara (MVA) boost
DNA prime with protein boost
DNA prime with vaccinia boost
DNA prime with virus-like particle (VLP) boost
DNA with CMV promotor
DNA with protein boost
fowlpoxvirus
gp120 depleted virus HZ321 (REMUNE(TM))
gp120 depleted whole killed virus
gp160 prime with gp120 boost
heat-shock protein (HSP70)
HIV-1 immunogen
HIV-1 peptide in filamentous bacteriophage major coat protein
inactivated HIV
ISCOM
lipopeptide
Listeria monocytogenes
modified vaccinia Ankara (MVA)
nanoparticle
peptide
peptide in cowpea mosaic virus (CPMV)
peptide presented on icosahedral protein scaffold
peptide prime with protein boost
protein
Salmonella
Streptococcus gordonii
vaccinia
vaccinia prime with gp120 boost
virus-like particle (VLP)
Vaccine strain
- ALL -
A clade
A clade 92RW020
A clade consensus
A clade UG5.94UG018
AG recombinant HZ321
B clade
B clade 1007
B clade 1035
B clade 89.6
B clade BH10
B clade BRU
B clade HXB2
B clade HXB3
B clade HXBc2
B clade IIIB
B clade JRFL
B clade LAI
B clade MN
B clade MN/LAI-2
B clade NL43
B clade SF2
B clade W61D
C clade 96ZM651
C clade 97ZA012
C clade consensus
D clade UG92005
M group Consensus
modified B clade IIIB
multiple epitope immunogen
Other
SIV
ZF1
Vaccine component
- ALL -
complete genome
Env
Gag
Gag-Pol
gp120
gp120 depleted virus
gp140
gp160
gp41
Nef
p17 Gag
p17/p24 Gag
p24 Gag
p25 Gag
Pol
Protease
Rev
RT
Tat
V3
Vif
virus
Vpr
Vpu
Adjuvant
- ALL -
aluminum hydroxide
aluminum phosphate
B7
Br-cAMP
Bupivacaine
CD40
CD80
CD86
Cholera toxin (CT)
Complete Freund's Adjuvant (CFA)
CpG immunostimulatory sequence (ISS)
E. coli mutant heat labile enterotoxin (LT-R72)
G-CSF
GM-CSF
GM-CSF/ENV chimera
Growth Hormone
IFNγ
IL-1α
IL-12
IL-15
IL-18
IL-2
IL-2/Ig
IL-4
IL-7
IL-8
Immune stimulating complexes (ISCOM)
Incomplete Freund's Adjuvant (IFA)
Keyhole Limpit Haemocyanin (KLH)
lipid A
M-CSF
macrophage activating lipopeptide-2 (MALP-2)
MCP1
MF59
MIP-1α
Montanide (ISA 51)
MPL-SE adjuvant
muramyl-dipeptide base adjuvant (Syntex)
Other
P3CSS
PLG
QS21
Quillaja saponin (Quil-A)
RANTES
Ribi adjuvant (MPL+TDM) (RIBI)
SDF-1α
Thymosin α-1
Tumor Necrosis Factor α (TNFα)
Tumor Necrosis Factor β (TNFβ)
ubiquitin
Species
- ALL -
chimpanzee
goat
guinea pig
human
macaque
mouse
rabbit
rat
transgenic mouse
MHC/HLA
- ALL -
A*0201
Ad
Class II I Ab
DP4
DP5
DQ
DQ2
DQ3
DQ5
DQ6
DQ7
DQ8
DQw7
DR
DR supermotif
DR(supermotif)
DR*W201
DR01*0401
DR0101
DR1
DR13.02
DR15/51
DR2
DR2 or DR3
DR2? plus others
DR3
DR4
DR4 and DR7
DR4(Dw10)
DR5
DR5(11.01)
DR5-11.01
DR5? plus others
DR6
DR7
DRB
DRB*0101
DRB*W201
DRB1*0101
DRB1*03
DRB1*0301
DRB1*0401
DRB1*0405
DRB1*0406
DRB1*0701
DRB1*1101
DRB1*13
DRB1*1301
DRB1*1302
DRB1*1501
DRB3*0202
DRB3*0301
DRB5*0101
DRS
DRw15(2)
DRw6
Dd
Ek
H-2 A
d
H-2 I-A
d
H-2 IA
b
H-2
b
H-2
bxk
H-2
d
H-2
d
H-2
i5
H-2
f
H-2
i5
H-2
k
H-2
s
H-2
sxd
H-2
t4
H-2Eα Eβ
k
H-2b
H-2d
H-2k
H2
d
H2b
HLA-DR
I-A
d
I-Ab and HLA-DR
Author
First
Last
Country
- ALL -
Brazil
Canada
Cote D'Ivoire
France
Gambia
India
Kenya
Netherlands
Senegal
South Africa
Spain
Sweden
United Kingdom
United States
Keywords
- ALL -
acute/early infection
adjuvant comparison
antagonism
assay standardization/improvement
binding affinity
characterizing CD8+ T cells
class I down-regulation by Nef
co-receptor
computational epitope prediction
cross-presentation by different HLA
dendritic cells
dynamics
early treatment
early-expressed proteins
enhancing activity
epitope processing
escape
genital and mucosal immunity
HAART, ART
HIV exposed persistently seronegative (HEPS)
immune dysfunction
immunodominance
immunoprophylaxis
immunotherapy
kinetics
memory cells
mother-to-infant transmission
mucosal immunity
optimal epitope
rate of progression
responses in children
review
subtype comparisons
superinfection
supertype
supervised treatment interruptions (STI)
TCR usage
Th1
Th2
therapeutic vaccine
vaccine antigen design
vaccine-induced epitopes
vaccine-specific epitope characteristics
variant cross-recognition or cross-neutralization
viral fitness and reversion
Questions or comments? Contact us at
immuno@lanl.gov
